- Home
- GWRS vs SMTI Comparison
GWRS vs SMTI Comparison
Compare GWRS & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWRS
- SMTI
- Stock Information
- Founded
- GWRS 2003
- SMTI 1982
- Country
- GWRS United States
- SMTI United States
- Employees
- GWRS N/A
- SMTI N/A
- Industry
- GWRS Water Supply
- SMTI Medical/Dental Instruments
- Sector
- GWRS Utilities
- SMTI Health Care
- Exchange
- GWRS Nasdaq
- SMTI Nasdaq
- Market Cap
- GWRS 265.4M
- SMTI 243.3M
- IPO Year
- GWRS 2010
- SMTI N/A
- Fundamental
- Price
- GWRS $9.95
- SMTI $35.01
- Analyst Decision
- GWRS
- SMTI Strong Buy
- Analyst Count
- GWRS 0
- SMTI 2
- Target Price
- GWRS N/A
- SMTI $50.00
- AVG Volume (30 Days)
- GWRS 41.1K
- SMTI 29.3K
- Earning Date
- GWRS 11-05-2025
- SMTI 11-11-2025
- Dividend Yield
- GWRS 3.06%
- SMTI N/A
- EPS Growth
- GWRS N/A
- SMTI N/A
- EPS
- GWRS 0.22
- SMTI N/A
- Revenue
- GWRS $54,270,000.00
- SMTI $97,241,894.00
- Revenue This Year
- GWRS $8.11
- SMTI $24.49
- Revenue Next Year
- GWRS $6.71
- SMTI $14.43
- P/E Ratio
- GWRS $45.60
- SMTI N/A
- Revenue Growth
- GWRS 4.33
- SMTI 34.29
- 52 Week Low
- GWRS $9.27
- SMTI $23.53
- 52 Week High
- GWRS $13.98
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- GWRS 54.15
- SMTI 60.17
- Support Level
- GWRS $9.64
- SMTI $33.00
- Resistance Level
- GWRS $9.93
- SMTI $35.49
- Average True Range (ATR)
- GWRS 0.23
- SMTI 1.35
- MACD
- GWRS 0.04
- SMTI -0.09
- Stochastic Oscillator
- GWRS 97.14
- SMTI 73.89
About GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operates within the State of Arizona.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.